Carrying one or two reduced-function CYP2C19 alleles is associated with an increased risk of major adverse cardiovascular events in people undergoing percutaneous coronary intervention and treated with clopidogrel by Ramirez Andrea H, Delaney Jessica T, Shuldiner Alan R in Evidence-based medicine (2011). PubMed

Abstract

Not available.

Discussed In Paper